Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Stock Short Interest Report for October

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 124,174 shares, an increase of 3,213.1% from the October 15th total of 3,748 shares. Based on an average daily volume of 1,427,500 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Advanced Medical Isotope Stock Performance

Shares of RDGL traded up $0.00 during mid-day trading on Tuesday, reaching $0.04. The stock had a trading volume of 84,085 shares, compared to its average volume of 603,227. The business has a fifty day moving average of $0.05 and a 200 day moving average of $0.06. Advanced Medical Isotope has a 12 month low of $0.04 and a 12 month high of $0.12.

About Advanced Medical Isotope

Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue. The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors. Advanced Medical Isotope has also developed IsoPet, a related isotope-based treatment for certain cancers in companion animals.